TipRanks
Advertisement
Advertisement

CH:FME Stock Latest News

Analyst Reiterates Sell on Fresenius Medical Care, Keeps $32 Price Target Amid Ongoing Operational and Leadership Risks
RatingsAnalyst Reiterates Sell on Fresenius Medical Care, Keeps $32 Price Target Amid Ongoing Operational and Leadership Risks
8h ago
FMS
Fresenius Medical trading resumes
PremiumThe Fly
Fresenius Medical trading resumes
1d ago
FMS
Fresenius Medical names Shervin Korangy as next CEO
PremiumThe Fly
Fresenius Medical names Shervin Korangy as next CEO
1d ago
FMS
Fresenius Medical trading halted, news pending
PremiumThe Fly
Fresenius Medical trading halted, news pending
1d ago
FMS
Fresenius Medical downgraded to Hold from Buy at Berenberg
PremiumThe Fly
Fresenius Medical downgraded to Hold from Buy at Berenberg
9d ago
FMS
Fresenius Medical price target raised to $25.80 from $25.50 at Bernstein
PremiumThe FlyFresenius Medical price target raised to $25.80 from $25.50 at Bernstein
2M ago
FMS
Fresenius Medical price target lowered to EUR 32.30 from EUR 37.40 at JPMorgan
Premium
The Fly
Fresenius Medical price target lowered to EUR 32.30 from EUR 37.40 at JPMorgan
2M ago
FMS
Fresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan Stanley
Premium
The Fly
Fresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan Stanley
2M ago
FMS
Fresenius Medical price target lowered to $25 from $26 at Truist
PremiumThe Fly
Fresenius Medical price target lowered to $25 from $26 at Truist
2M ago
FMS
Fresenius Medical Care: Sell Rating Reiterated as Growth Concerns Persist and $32 Price Target Remains Unchanged
PremiumRatings
Fresenius Medical Care: Sell Rating Reiterated as Growth Concerns Persist and $32 Price Target Remains Unchanged
2M ago
FMS
0H9X Earnings this Week: How Will it Perform?
PremiumPre-Earnings
0H9X Earnings this Week: How Will it Perform?
2M ago
Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas
PremiumThe Fly
Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas
2M ago
FMS
Sell Rating Reiterated on Deteriorating Fundamentals, Earnings Headwinds and Unchanged $32 Price Target
PremiumRatingsSell Rating Reiterated on Deteriorating Fundamentals, Earnings Headwinds and Unchanged $32 Price Target
3M ago
FMS
Fresenius Medical price target raised to EUR 41 from EUR 40 at Citi
Premium
The Fly
Fresenius Medical price target raised to EUR 41 from EUR 40 at Citi
3M ago
FMS
Fresenius Medical initiated with a Market Perform at Bernstein
Premium
The Fly
Fresenius Medical initiated with a Market Perform at Bernstein
3M ago
FMS
PremiumRatings
David Adlington Reiterates Sell on Fresenius Medical Care, Keeps $37.4 Price Target Amid Valuation and Margin Concerns
4M ago
FMS
PremiumRatings
Sell Rating Reaffirmed on Limited Earnings Visibility and Competitive Pressures; €32 Price Target Maintained
4M ago
FMS
Fresenius Medical launches first tranche of share buyback program
PremiumThe Fly
Fresenius Medical launches first tranche of share buyback program
4M ago
FMS
Fresenius Medical announces EUR 1B share buyback program
PremiumThe Fly
Fresenius Medical announces EUR 1B share buyback program
5M ago
FMS
Fresenius Medical reappoints CFO Martin Fischer
PremiumThe FlyFresenius Medical reappoints CFO Martin Fischer
5M ago
FMS
Premium
Ratings
Fresenius Medical Care: Sell Rating Maintained as EBIT Headwinds Cloud Growth Outlook; €32 Price Target Reaffirmed
5M ago
FMS
Fresenius Medical price target lowered to EUR 40 from EUR 42 at Deutsche Bank
Premium
The Fly
Fresenius Medical price target lowered to EUR 40 from EUR 42 at Deutsche Bank
5M ago
FMS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >